EVAX
Price
$0.80
Change
+$0.01 (+1.27%)
Updated
Nov 30, 6:59 PM EST
123 days until earnings call
VBIV
Price
$0.62
Change
+$0.01 (+1.64%)
Updated
Nov 30, 6:59 PM EST
Ad is loading...

Compare predictions EVAX vs VBIV

Header iconEVAX vs VBIV Comparison
Open Charts EVAX vs VBIVBanner chart's image
Evaxion Biotech A/S American Depositary Share
Price$0.80
Change+$0.01 (+1.27%)
Volume$166.36K
CapitalizationN/A
VBI Vaccines
Price$0.62
Change+$0.01 (+1.64%)
Volume$33.78K
CapitalizationN/A
View a ticker or compare two or three
EVAX vs VBIV Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
EVAX vs. VBIV commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and VBIV is a StrongBuy.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (EVAX: $0.80 vs. VBIV: $0.62)
Brand notoriety: EVAX and VBIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 300% vs. VBIV: 28%
Market capitalization -- EVAX: $22.61M vs. VBIV: $14M
EVAX [@Biotechnology] is valued at $22.61M. VBIV’s [@Biotechnology] market capitalization is $14M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileVBIV’s FA Score has 1 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • VBIV’s FA Score: 1 green, 4 red.
According to our system of comparison, VBIV is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 2 TA indicator(s) are bullish while VBIV’s TA Score has 6 bullish TA indicator(s).

  • EVAX’s TA Score: 2 bullish, 7 bearish.
  • VBIV’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VBIV is a better buy in the short-term than EVAX.

Price Growth

EVAX (@Biotechnology) experienced а -0.12% price change this week, while VBIV (@Biotechnology) price change was +11.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.54%. For the same industry, the average monthly price growth was +27.11%, and the average quarterly price growth was +23.26%.

Reported Earning Dates

EVAX is expected to report earnings on Apr 02, 2024.

VBIV is expected to report earnings on Aug 09, 2023.

Industries' Descriptions

@Biotechnology (+2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for EVAX with price predictions.
OPEN
A.I.dvisor published
a Summary for VBIV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EVAX($22.6M) has a higher market cap than VBIV($14M). EVAX YTD gains are higher at: -54.986 vs. VBIV (-94.757). EVAX has higher annual earnings (EBITDA): -24.28M vs. VBIV (-104.08M). VBIV has more cash in the bank: 35.5M vs. EVAX (7.12M). EVAX has less debt than VBIV: EVAX (10.5M) vs VBIV (52.7M). VBIV has higher revenues than EVAX: VBIV (8.12M) vs EVAX (0).
EVAXVBIVEVAX / VBIV
Capitalization22.6M14M161%
EBITDA-24.28M-104.08M23%
Gain YTD-54.986-94.75758%
P/E RatioN/AN/A-
Revenue08.12M-
Total Cash7.12M35.5M20%
Total Debt10.5M52.7M20%
FUNDAMENTALS RATINGS
VBIV: Fundamental Ratings
VBIV
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVAXVBIV
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIAF1.660.31
+22.96%
bioAffinity Technologies
BBSI110.372.87
+2.67%
Barrett Business Services
PTC157.361.87
+1.20%
PTC
GBTG6.22-0.04
-0.64%
Global Business Travel Group
BENF0.49-0.11
-18.35%
Beneficient

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with ATRA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+2.44%
ATRA - EVAX
40%
Loosely correlated
-4.77%
IKNA - EVAX
28%
Poorly correlated
+3.57%
NRIX - EVAX
27%
Poorly correlated
+1.47%
SPRB - EVAX
27%
Poorly correlated
+2.92%
ORMP - EVAX
25%
Poorly correlated
+0.91%
More